12:07 PM EDT, 04/29/2025 (MT Newswires) -- The European stock markets closed mostly higher in Tuesday trading as The Stoxx Europe 600 gained 0.41%, Germany's DAX increased 0.69%, the FTSE 100 was up 0.55%, and the Swiss Market Index advanced 0.32%, while France's CAC 40 was off 0.24%.

The European Commission's Economic Sentiment Indicator for the EU and euro area each fell 1.4 points in April to 94.4 points and 93.6 points respectively. Meanwhile, the Employment Expectations Indicator for the EU was down 0.7 points to 96.9, while the indicator for the euro area was unchanged at 96.5. Both indicators continued to decline from its long-term averages.

In Spain, the flash estimate for the annual inflation rate for April declined to 2.2% from 2.3% the previous month, according to the Spanish Statistical Office.

And in corporate news, BP reported Q1 underlying replacement cost profit Tuesday of $0.53 per diluted American depositary share, down from $0.97 a year earlier. Sales and other operating revenue for the quarter ended March 31 were $46.91 billion, down from $48.80 billion a year earlier.

Shares of BP declined 2.3% in London trading.

HSBC reported Q1 earnings Tuesday of $0.39 per diluted share, down from $0.54 a year earlier. Revenue for the quarter ended March 31 was $17.65 billion compared with $20.75 billion a year earlier. The company said it plans a share buyback of up to $3 billion, expected to begin shortly after its annual general meeting scheduled for May 2.

Shares of HSBC gained 3% on the FTSE

Deutsche Bank reported Q1 earnings Tuesday of 0.99 euros ($1.13) per diluted share, up from 0.69 euros a year earlier. Analysts polled by FactSet expected 0.81 euros. Revenue for the quarter ended March 31 was 8.52 billion euros, up from 7.78 billion euros a year earlier. Analysts surveyed by FactSet expected euros 8.36 billion.

Shares of Deutsche Bank closed 5.5% higher in Frankfurt.

Novo Nordisk and Hims & Hers Health have formed a partnership that will allow US consumers to access NovoCare pharmacy directly through the Hims platform with a bundled offering of all dose strengths of Wegovy and a Hims membership for $599 per month, the companies said Tuesday.

Shares of Novo Nordisk rose 2.4% in Copenhagen.